Brighton Jones LLC Has $2.74 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Brighton Jones LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,047 shares of the medical equipment provider’s stock after purchasing an additional 1,260 shares during the quarter. Brighton Jones LLC’s holdings in Intuitive Surgical were worth $2,742,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. Aaron Wealth Advisors LLC increased its position in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares in the last quarter. Crown Wealth Group LLC increased its position in Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after acquiring an additional 20 shares during the period. FSM Wealth Advisors LLC increased its position in Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after acquiring an additional 20 shares during the period. CFO4Life Group LLC increased its position in Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after acquiring an additional 20 shares during the period. Finally, J. W. Coons Advisors LLC increased its position in Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after acquiring an additional 20 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research report on Wednesday. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday. Finally, HSBC upped their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $602.32.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,031 shares of company stock worth $14,177,895. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Down 0.9%

ISRG opened at $546.51 on Monday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a fifty day moving average of $458.09 and a 200-day moving average of $497.11. The stock has a market cap of $195.91 billion, a PE ratio of 72.29, a price-to-earnings-growth ratio of 5.02 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the company posted $1.84 earnings per share. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.